Natriumklorid-Glucos, Viaflo Baxter (Sodium Chloride, Glucose)

Sodium chloride and glucose, the active ingredient in Natriumklorid-Glucos, Viaflo Baxter, is an electrolyte and carbohydrate solution presented as an injection solution for intravenous use. It provides fluid, electrolyte and energy replacement in patients requiring parenteral hydration or nutrition.

GNH USA supplies Natriumklorid-Glucos, Viaflo Baxter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and clinics worldwide.

Natriumklorid-Glucos, Viaflo Baxter is used in clinical settings to address fluid and electrolyte disturbances and to supply energy via carbohydrate infusion.

Dehydration: restores intravascular volume and corrects fluid deficits. Electrolyte imbalance: supplies sodium and chloride to normalize plasma electrolyte concentrations. Parenteral nutrition: provides glucose as an energy substrate during intravenous feeding.

Adverse reactions may occur with intravenous administration of electrolyte and carbohydrate solutions.

Common Side Effects: - Phlebitis or infusion site irritation - Mild hypernatremia - Transient hyperglycemia - Fluid overload in susceptible patients - Electrolyte disturbances (e.g., mild hypokalemia)

Serious or Rare Side Effects: - Severe hypernatremia leading to neurologic symptoms - Anaphylactic reaction or severe hypersensitivity - Pulmonary edema due to excessive fluid administration

When using Natriumklorid-Glucos, careful patient assessment and monitoring are essential. - Assess fluid status: avoid overload in patients with heart failure or renal impairment. - Monitor electrolytes: check serum sodium and chloride regularly during therapy. - Check blood glucose: monitor for hyperglycemia, especially in diabetic patients. - Use aseptic technique: prevent contamination during preparation and administration. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Potential drug interactions should be evaluated before initiating therapy.

Major Interactions (Avoid): - Concurrent hypertonic saline: risk of severe hypernatremia. - High‑dose insulin therapy: may cause rapid shifts in glucose levels. - Loop diuretics: can exacerbate electrolyte loss.

Moderate Interactions (Monitor Closely): - Potassium supplements: may lead to hyperkalemia when combined with potassium‑containing solutions. - Cardiac glycosides: monitor for electrolyte‑induced changes in cardiac conduction. - Blood transfusions: may affect overall fluid balance and require adjustment of infusion rates.